Andere Sprachen bioAffinity Technologies, Inc.

Aktien

A3DK86

US09076W1099

BIAF

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 29.04.2024			% 5 Tage	% 1. Jan.
2,53 ^USD	+6,75 %		-15,67 %	+72,05 %

01.04.	BioAffinity Technologies, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
08.03.	BioAffinity Technologies schließt Aktienangebot in Höhe von $2,5 Millionen ab	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth	24.04.
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening	09.04.
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results	01.04.
BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	20.03.
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	11.03.
BioAffinity Technologies Closes $2.5 Million Equity Offerings	08.03.
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	08.03.
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	08.03.
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	06.03.
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	06.03.
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung	06.03.
BioAffinity Technologies, Inc. announced that it expects to receive $2.624 million in funding	06.03.
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung	05.03.
BioAffinity Technologies News Update	21.02.
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice	07.02.
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice	06.02.
BioAffinity Technologies, Inc. Appoints Sandeep Bansal to Medical and Scientific Advisory Board	06.02.
BioAffinity Technologies In The News	30.01.
BioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer	23.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen bioAffinity Technologies, Inc.

Aktien

A3DK86

US09076W1099

BIAF

Andere Sprachen

Filter